1. Home
  2. FATE vs RGP Comparison

FATE vs RGP Comparison

Compare FATE & RGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FATE
  • RGP
  • Stock Information
  • Founded
  • FATE 2007
  • RGP 1996
  • Country
  • FATE United States
  • RGP United States
  • Employees
  • FATE N/A
  • RGP N/A
  • Industry
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • RGP Business Services
  • Sector
  • FATE Health Care
  • RGP Consumer Discretionary
  • Exchange
  • FATE Nasdaq
  • RGP Nasdaq
  • Market Cap
  • FATE 177.7M
  • RGP 178.9M
  • IPO Year
  • FATE 2013
  • RGP 2006
  • Fundamental
  • Price
  • FATE $1.18
  • RGP $5.34
  • Analyst Decision
  • FATE Hold
  • RGP Sell
  • Analyst Count
  • FATE 7
  • RGP 1
  • Target Price
  • FATE $3.83
  • RGP $5.00
  • AVG Volume (30 Days)
  • FATE 2.0M
  • RGP 207.5K
  • Earning Date
  • FATE 08-12-2025
  • RGP 07-17-2025
  • Dividend Yield
  • FATE N/A
  • RGP 9.18%
  • EPS Growth
  • FATE N/A
  • RGP N/A
  • EPS
  • FATE N/A
  • RGP N/A
  • Revenue
  • FATE $13,335,000.00
  • RGP $560,189,000.00
  • Revenue This Year
  • FATE N/A
  • RGP N/A
  • Revenue Next Year
  • FATE N/A
  • RGP $3.85
  • P/E Ratio
  • FATE N/A
  • RGP N/A
  • Revenue Growth
  • FATE 105.85
  • RGP N/A
  • 52 Week Low
  • FATE $0.66
  • RGP $4.81
  • 52 Week High
  • FATE $5.92
  • RGP $12.19
  • Technical
  • Relative Strength Index (RSI)
  • FATE 46.59
  • RGP 48.37
  • Support Level
  • FATE $1.16
  • RGP $5.38
  • Resistance Level
  • FATE $1.32
  • RGP $5.70
  • Average True Range (ATR)
  • FATE 0.16
  • RGP 0.19
  • MACD
  • FATE -0.04
  • RGP 0.03
  • Stochastic Oscillator
  • FATE 8.33
  • RGP 44.62

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

About RGP Resources Connection Inc.

Resources Connection Inc provides consulting and business initiative support services predominantly through its operative subsidiary, Resources Global Professionals. It has two segments RGP ( Resources Global Professionals.) and Sitrick. The RGP segment is focused on delivering consulting services catering to its client's operational needs and change initiatives utilizing a combination of bench and on-demand, talent. The Sitrick segment provides corporate, financial, transactional, and crisis communication and management services. The company generates a majority of its revenue from the RGP segment. Geographically, it derives its key revenue from North America and the rest from Europe and the Asia Pacific region.

Share on Social Networks: